| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Toxicology, Oncology and Molecular Pathology Unit (A.C., M.P., M.D., C.C., S.M., G.M.L.-C.), University of Cagliari, 09124 Cagliari, Italy; Department of Pharmaceutical Chemistry (T.S.S.), University of California-San Francisco, San Francisco, California 94143; and Dipartimento di Scienze dellUomo e dellAmbiente (G.C.), University of Pisa, Pisa 56126, Italy
Address all correspondence and requests for reprints to: Dr. A. Columbano, Dipartimento di Tossicologia, Sezione di Oncologia e Patologia Molecolare, Via Porcell 4, 09124 Cagliari, Italy. E-mail: columbano{at}unica.it.
Thyroid hormones regulate cell growth, cell differentiation, and metabolic functions via interaction with the thyroid hormone nuclear receptors (TRs). Recently, a small class of halogen-free high-affinity thyroid hormone agonists has been developed that are highly selective for the TRß subtype. Because of the selective hyperthyroidism generated by one of these agonists, GC-1, this compound has the potential to be developed as a new therapeutic agent for the treatment of a variety of metabolic disturbances, including lipid disorders and obesity; thus, it becomes important to determine whether GC-1 has other unknown effects on potential target organs. The purpose of this study was to investigate the effect of GC-1 on cell proliferation in rat liver and pancreas. Rats treated with GC-1 (50 or 100 µg/100 g body weight) were killed at different time points. Hepatic and pancreatic cell proliferation was monitored by immunohistochemical determination of bromodeoxyuridine incorporation. The expression of cell cycle-related genes was analyzed by Northern and Western analysis. The results show that GC-1 strongly stimulates rat hepatocyte proliferation in the absence of tissue injury. Although GC-1-induced hepatocyte proliferation was associated with a rapid increase in cyclin D1 mRNA levels, no change in the expression of c-jun and c-fos was observed. GC-1 also induced massive pancreatic cell proliferation. The results indicate that the TRß-selective agonist GC-1 is a strong mitogen for hepatocytes and pancreatic acinar cells. Furthermore, they suggest that the TRß receptor is the mediator for the mitogenic activity of thyroid hormone and other thyromimetics.
This article has been cited by other articles:
![]() |
E. Kress, A. Rezza, J. Nadjar, J. Samarut, and M. Plateroti The Frizzled-related sFRP2 Gene Is a Target of Thyroid Hormone Receptor {alpha}1 and Activates {beta}-Catenin Signaling in Mouse Intestine J. Biol. Chem., January 9, 2009; 284(2): 1234 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perra, M. Pibiri, P. Sulas, G. Simbula, G. M. Ledda-Columbano, and A. Columbano {alpha}-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model Carcinogenesis, January 1, 2008; 29(1): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |